Merck fined $38M in Spain for hindering generic competition for NuvaRing

Merck & Co. has been hit with a fine in Spain for alleged anti-competitive practices. The Spanish antitrust watchdog National Commission on Markets and Competition (CNMC) has docked the New Jersey pharma giant 39 million euros ($38.45 million) for hindering a generic version of its NuvaRing contraceptive device.